PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 201 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2015. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $2,429,000 | -16.2% | 52,980 | +8.1% | 0.02% | -15.8% |
Q2 2018 | $2,897,000 | +2.6% | 48,989 | +18.1% | 0.02% | +171.4% |
Q1 2018 | $2,823,000 | -20.9% | 41,484 | +14.8% | 0.01% | -12.5% |
Q4 2017 | $3,571,000 | -29.7% | 36,125 | -14.9% | 0.01% | -33.3% |
Q3 2017 | $5,083,000 | +26.6% | 42,449 | -7.6% | 0.01% | +9.1% |
Q2 2017 | $4,016,000 | +86.3% | 45,950 | -20.7% | 0.01% | +83.3% |
Q1 2017 | $2,156,000 | +21.7% | 57,981 | +0.4% | 0.01% | +20.0% |
Q4 2016 | $1,772,000 | -49.1% | 57,731 | +11.1% | 0.01% | -54.5% |
Q3 2016 | $3,483,000 | +912.5% | 51,947 | +349.6% | 0.01% | +1000.0% |
Q2 2016 | $344,000 | -83.0% | 11,555 | -83.2% | 0.00% | -83.3% |
Q1 2016 | $2,025,000 | -51.9% | 68,932 | +28.3% | 0.01% | -50.0% |
Q4 2015 | $4,211,000 | +39.1% | 53,715 | +33.7% | 0.01% | +33.3% |
Q3 2015 | $3,028,000 | -71.9% | 40,187 | -56.4% | 0.01% | -66.7% |
Q2 2015 | $10,767,000 | -4.9% | 92,225 | +92.3% | 0.03% | 0.0% |
Q1 2015 | $11,326,000 | +27.4% | 47,970 | +2.1% | 0.03% | +22.7% |
Q4 2014 | $8,891,000 | +10.8% | 46,973 | +39.7% | 0.02% | +15.8% |
Q3 2014 | $8,022,000 | +78.9% | 33,625 | -50.5% | 0.02% | +72.7% |
Q2 2014 | $4,483,000 | -28.1% | 67,921 | +13.5% | 0.01% | -38.9% |
Q1 2014 | $6,234,000 | +28.5% | 59,860 | +27.8% | 0.02% | +20.0% |
Q4 2013 | $4,850,000 | – | 46,844 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARVARD MANAGEMENT CO INC | 600,000 | $45,216,000 | 3.56% |
Avalon Global Asset Management LLC | 32,900 | $2,479,000 | 1.79% |
CORNERSTONE CAPITAL MANAGEMENT LLC | 495,145 | $37,314,000 | 1.58% |
BB BIOTECH AG | 521,991 | $39,337,000 | 1.25% |
WEATHERBIE CAPITAL, LLC | 137,041 | $10,327,000 | 1.20% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $428,527,000 | 1.19% |
TOBAM | 318,384 | $23,994,000 | 0.94% |
Orbimed Advisors | 1,195,500 | $90,093,000 | 0.91% |
Capital International Sarl | 109,405 | $8,245,000 | 0.74% |
CAPITAL INTERNATIONAL LTD /CA/ | 145,697 | $10,980,000 | 0.73% |